Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis

被引:29
作者
Mazzola, Rosario [1 ,2 ]
Ricchetti, Francesco [1 ]
Fersino, Sergio [1 ]
Fiorentino, Alba [1 ]
Levra, Niccolo Giaj [1 ]
Di Paola, Gioacchino [3 ]
Ruggieri, Ruggero [1 ]
Alongi, Filippo [1 ]
机构
[1] Sacro Cuore Don Calabria Hosp, Dept Radiat Oncol, Negrar Verona, Italy
[2] Univ Palermo, Dept Radiat Oncol Sch, Palermo, Italy
[3] Univ Palermo, Stat Sci Fac, Palermo, Italy
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2016年 / 38卷
关键词
mucositis; head neck cancer; volumetric modulated arc radiotherapy (VMAT); organ sparing; NECK-CANCER; ADVANCED HEAD; ARC THERAPY; RADIOTHERAPY; CHEMOTHERAPY; DELINEATION; DYSPHAGIA; IMRT; MANAGEMENT; SEVERITY;
D O I
10.1002/hed.24106
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to assess predictors of mucositis in oropharyngeal and oral cavity cancer after definitive or adjuvant volumetric modulated arc radiotherapy (VMAT) +/- chemotherapy. Methods. Fifty patients were evaluated. Statistical analysis was performed for the following parameters as potential predictors of mucositis >= G2: total oral mucosa and oral mucosa minus target high-low radiation dose regions (planning target volumes [PTVs]), mean dose (D-mean), maximum dose (D-max), chemotherapy, weight loss, and dysphagia. Results. Mucositis >= G2 was found to be statistically related to chemotherapy, weight loss, dysphagia >= G2, total oral mucosa D-mean >= 50 Gy and D-max >= 65 Gy, V-45 (Gy) >40%, V-50 Gy >30%, and V-55 Gy >20% of the oral mucosa minus target PTVs. A ratio between total oral mucosa and oral mucosa minus target PTVs >2.5 is related to G3 mucositis (p = .03). Conclusion. New parameters were found as predictors of moderate-severe mucositis. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:E815 / E819
页数:5
相关论文
共 36 条
[31]   How fast is repopulation of tumor cells during the treatment gap? [J].
Tarnawski, R ;
Fowler, J ;
Skladowski, K ;
Swierniak, A ;
Suwinski, R ;
Maciejewski, B ;
Wygoda, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01) :229-236
[32]   TIME-DOSE FACTORS IN RADIOTHERAPY - A REVIEW OF THE HUMAN DATA [J].
THAMES, HD ;
BENTZEN, SM ;
TURESSON, I ;
OVERGAARD, M ;
VANDENBOGAERT, W .
RADIOTHERAPY AND ONCOLOGY, 1990, 19 (03) :219-235
[33]   Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review [J].
Trotti, A ;
Bellm, LA ;
Epstein, JB ;
Frame, D ;
Fuchs, HJ ;
Gwede, CK ;
Komaroff, E ;
Nalysnyk, L ;
Zilberberg, MD .
RADIOTHERAPY AND ONCOLOGY, 2003, 66 (03) :253-262
[34]   Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: A treatment planning comparison with fixed field IMRT [J].
Vanetti, Eugenio ;
Clivio, Alessandro ;
Nicolini, Giorgia ;
Fogliata, Antonella ;
Ghosh-Laskar, Sarbani ;
Agarwal, Jai Prakash ;
Upreti, Ritu Raj ;
Budrukkar, Ashwini ;
Murthy, Vedang ;
Deshpande, Deepak Dattatray ;
Shrivastava, Shyam Kishore ;
Dinshaw, Ketayun Ardeshir ;
Cozzi, Luca .
RADIOTHERAPY AND ONCOLOGY, 2009, 92 (01) :111-117
[35]   VOLUMETRIC INTENSITY-MODULATED ARC THERAPY VS. CONVENTIONAL IMRT IN HEAD-AND-NECK CANCER: A COMPARATIVE PLANNING AND DOSIMETRIC STUDY [J].
Verbakel, Wilko F. A. R. ;
Cuijpers, Johan P. ;
Hoffmans, Daan ;
Bieker, Michael ;
Slotman, Ben J. ;
Senan, Suresh .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (01) :252-259
[36]   ACUTE NORMAL TISSUE REACTIONS IN HEAD-AND-NECK CANCER PATIENTS TREATED WITH IMRT: INFLUENCE OF DOSE AND ASSOCIATION WITH GENETIC POLYMORPHISMS IN DNA DSB REPAIR GENES [J].
Werbrouck, Joke ;
De Ruyck, Kim ;
Duprez, Frederic ;
Veldeman, Liv ;
Claes, Kathleen ;
Van Eijkeren, Marc ;
Boterberg, Tom ;
Willems, Petra ;
Vral, Anne ;
De Neve, Wilfried ;
Thierens, Hubert .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04) :1187-1195